Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience.

Demary, Winfried; Schwenke, Holger; Rockwitz, Karin; Kästner, Peter; Liebhaber, Anke; Schoo, Ulrich; Hübner, Georg; Pichlmeier, Uwe; Guimbal-Schmolck, Cécile; Müller-Ladner, Ulf

Demary, Winfried; Schwenke, Holger; Rockwitz, Karin; Kästner, Peter; Liebhaber, Anke; Schoo, Ulrich; Hübner, Georg; Pichlmeier, Uwe; Guimbal-Schmolck, Cécile; Müller-Ladner, Ulf.

Afiliação

Demary W; Private practice, Hildesheim, Germany.
Schwenke H; Private practice, Dresden, Germany.
Rockwitz K; Private practice, Goslar, Germany.
Kästner P; Outpatient Rheumatism Center, Erfurt, Germany.
Liebhaber A; Private practice, Halle, Germany.
Schoo U; Private practice, Rheine, Germany.
Hübner G; Private practice, Lingen, Germany.
Pichlmeier U; medac GmbH, Hamburg, Germany.
Guimbal-Schmolck C; medac GmbH, Hamburg, Germany.
Müller-Ladner U; Department of Rheumatology and Clinical Immunology, Kerckhoff-Klinik GmbH, Bad Nauheim, Germany.

Patient Prefer Adherence ; 8: 1061-71, 2014.

Article em En | MEDLINE | ID: mdl-25125973

Palavras-chave

injection device; methotrexate

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Aspecto: Patient_preference Idioma: En Revista: Patient Prefer Adherence Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google